No Chart Data Available
No Record Found
No Record Found
Sector
PharmaceuticalsOpen
₹319.9Prev. Close
₹306Turnover(Lac.)
₹25.24Day's High
₹319.9Day's Low
₹290.552 Week's High
₹62552 Week's Low
₹290.5Book Value
₹19.93Face Value
₹10Mkt Cap (₹ Cr.)
363.43P/E
0EPS
0Divi. Yield
0No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 12.03 | 12.03 | 10.56 | 10.56 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 13.09 | 20.74 | 3.98 | 0.72 |
Net Worth | 25.12 | 32.77 | 14.54 | 11.28 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 43.2 | 53.68 | 43.76 | 39.61 |
yoy growth (%) | -19.52 | 22.65 | 10.47 | 21.88 |
Raw materials | -14.57 | -13.61 | -9.55 | -9.19 |
As % of sales | 33.72 | 25.36 | 21.83 | 23.2 |
Employee costs | -13.06 | -16.02 | -12.82 | -11.33 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | -6.57 | 1.21 | 3.4 | 3.23 |
Depreciation | -0.81 | -0.67 | -0.5 | -0.56 |
Tax paid | 1.62 | -0.33 | -1.1 | -1.02 |
Working capital | 0.44 | -18.69 | 19.58 | 4.58 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -19.52 | 22.65 | 10.47 | 21.88 |
Op profit growth | -96.11 | -43.12 | 11.78 | 20.74 |
EBIT growth | -121.69 | -50.88 | 17.13 | 21.95 |
Net profit growth | -664.56 | -61.88 | 4.42 | 27.63 |
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
Gross Sales | 120.33 | 108.26 | 93.41 | 80.35 | 62.07 |
Excise Duty | 0 | 5.1 | 4.17 | 4.08 | 3.1 |
Net Sales | 120.33 | 103.15 | 89.24 | 76.27 | 58.97 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 1.82 | 0.3 | 3.12 | 1.14 | 0.11 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,700.55 | 87.3 | 4,08,018.91 | 564.22 | 0.94 | 4,511.27 | 99.24 |
Divis Laboratories Ltd DIVISLAB | 6,356.75 | 67.13 | 1,68,751.74 | 696 | 0.47 | 2,660 | 578.26 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 4,004.85 | 63.51 | 1,35,542.32 | 597 | 0.15 | 2,707 | 249.82 |
Cipla Ltd CIPLA | 1,434.6 | 22.29 | 1,15,882.86 | 1,210.53 | 1.12 | 4,495.16 | 411.56 |
Lupin Ltd LUPIN | 2,195 | 18.79 | 1,00,267.34 | 1,357.35 | 0.55 | 3,852.79 | 595.98 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Non Executive Dir.
Ramesh Vangal
E D & Wholetime Director
K Anilkumar
Non Executive Director
Kodikannath Jayarajan
Non Executive Director
Utkarsh Singh
Independent Non Exe. Director
Saif Khan
Independent Non Exe. Director
Shilpa Kiran Gududur
Independent Non Exe. Director
Rajesh Sharma
Independent Non Exe. Director
SAMIR DHAWAN
Independent Non Exe. Director
Kshiti Ranjan Das
Company Sec. & Compli. Officer
Priyanka Gangwar
VII/415 Nedumbassery,
Athani P O Aluva,
Kerala - 683585
Tel: 91-484-2476301/2/3/4
Website: http://www.keralaavurveda.biz
Email: investor@keralaayurveda.biz; info@keralaayurveda.b
Kences Tower,
2nd Floor No 1, Ramakrishna Street,
Chennai - 600 017
Tel: 91-044-28140801/803
Website: www.integratedindia.in
Email: sureshbabu@iepindia.com/yesbalu@iepindia.com
Summary
Kerala Ayurveda Limited was established on 6th July 1992. The Company is engaged in manufacture of Ayurveda products, Ayurveda Research, Academies, Clinics, Hospitals, Ayurvedic Wellness Resorts and S...
Read More
Reports by Kerala Ayurveda Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.